On ECHEMI
Home > Drugs > Zhengzhou Fusheng Pharmaceutical Co., Ltd.
Zhengzhou Fusheng Pharmaceutical Co., Ltd.
  • Founded in:

    2004-03-23
  • Country:

    China China
  • Address:

    No. 34, Dongqing Street, Zhengzhou High-tech Zone
  • Tax NO.:

    91410100760211601W
  • Registered Funds:

    31 million yuan
  • Email:

Related Drugs
Inosine Tablets
Each tablet of this product contains 0.2 grams of the main ingredient inosine, and the auxiliary materials are starch, dextrin and sugar.
Name Description Content CAS NO. Registered Holders
Inosine

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

More

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

0.2g 58-63-9 8
Dry yeast flakes
Each tablet of this product contains 0.3 grams of dry yeast as the main ingredient.
Name Description Content CAS NO. Registered Holders
Yeast extract

This product is the dried bacteria of brewer's yeast, rich in B vitamins, and has an auxiliary therapeutic effect on indigestion

More

This product is the dried bacteria of brewer's yeast, rich in B vitamins, and has an auxiliary therapeutic effect on indigestion

0.3g 8013-01-2 4
Levamisole Hydrochloride Tablets
The main ingredient of this product is: Levamisole hydrochloride. Its chemical name is: (S)-(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride.
Name Description Content CAS NO. Registered Holders
Levamisole hydrochloride

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune preparation functions.

More

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune preparation functions.

16595-80-5 7
Betahistine Hydrochloride Tablets
The main ingredient of this product is betahistine hydrochloride.
Name Description Content CAS NO. Registered Holders
Betahistine dihydrochloride

It has a significant dilating effect on the cerebral and cardiovascular systems, especially the vertebral artery system, significantly increasing the blood flow to the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure; increasing the blood flow to the cochlea and anterior base, eliminating inner ear vertigo, tinnitus and ear closure; increasing capillary permeability, promoting the absorption of extracellular fluid, and eliminating intracellular lymphatic edema; counteracting the vasoconstrictive effect of catecholamines and lowering arterial pressure, inhibiting plasma coagulation and ADP-induced platelet aggregation, and prolonging the time of thrombosis in vitro in rats; and having a slight diuretic effect.

More

It has a significant dilating effect on the cerebral and cardiovascular systems, especially the vertebral artery system, significantly increasing the blood flow to the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure; increasing the blood flow to the cochlea and anterior base, eliminating inner ear vertigo, tinnitus and ear closure; increasing capillary permeability, promoting the absorption of extracellular fluid, and eliminating intracellular lymphatic edema; counteracting the vasoconstrictive effect of catecholamines and lowering arterial pressure, inhibiting plasma coagulation and ADP-induced platelet aggregation, and prolonging the time of thrombosis in vitro in rats; and having a slight diuretic effect.

5579-84-0 21
Metronidazole tablets
【Main ingredient】Metronidazole 【Chemical name】2-methyl-5-nitroimidazole-1-ethanol
Name Description Content CAS NO. Registered Holders
Metronidazole

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1~2mg/L, the histolytica amoeba can undergo morphological changes in 6~20 hours and all are killed within 24 hours. When the concentration is 0.2mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. It has a carcinogenic effect on some animals.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1~2mg/L, the histolytica amoeba can undergo morphological changes in 6~20 hours and all are killed within 24 hours. When the concentration is 0.2mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. It has a carcinogenic effect on some animals.

443-48-1 39
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.